Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
New approach to rare disease drug development yields first research results
PFAS in medicines can often be replaced with alternatives
Polyomaviruses: new approaches to prevention and treatment
ten23 health obtains Swissmedic licences for Basel and Visp facilities
SK bioscience launches initiative to reduce uncertainty in vaccine-development decisions
Human embryo gene-correction research approved
New immunotherapy strategy targets aggressive brain tumours and their fuel
New tool gives scientists clearer view of DNA regulation